Comparison of Sonograms and Liver Histologic Findings in Patients with Chronic Hepatitis C Virus Infection
|
|
- Bernice O’Connor’
- 7 years ago
- Views:
Transcription
1 Comparison of Sonograms and Liver Histologic Findings in Patients with Chronic Hepatitis C Virus Infection Rosalyn Kutcher, MD, Gail S. Smith, MD, Filiz Sen, MD, Scott F. Gelman, MD, Sumi Mitsudo, MD, Swan N. Thung, MD, John F. Reinus, MD Gray scale ultrasonographic images of the liver were correlated with histologic findings in patients with chronic hepatitis C virus infection. The gray scale patterns of 64 livers with chronic hepatitis C virus infection were categorized as normal, fatty, fibrofatty, fibrotic, or inflammatory and were graded as mild, moderate, or severe. Liver biopsy specimens also were analyzed for the presence of fat, inflammation, and fibrosis and graded similarly. No correlation was found between fatty and fibrofatty sonographic findings with any of the three histologic patterns. Correlations were found between fibrotic sonographic findings and both fibrotic and inflammatory histologic findings (r = 0.27; P = 0.03). lthough some pathologic features of liver disease were detected by ultrasonography, no useful correlation was noted between results of sonography and histologic examination. KEY WORDS: Hepatitis C virus; Liver, ultrasonography; Infection, hepatitic C. H epatitis C virus is the most common cause of chronic hepatitis in the United States. 1 In patients with chronic HCV infection, REVITIONS HCV, Hepatitis C virus; LT, lanine aminotransferase; SD, Standard deviation; ULN, Upper limit of normal Received July 31, 1997, from the Departments of Radiology (R.K., G.S.S.), Pathology (F.S., S.M.), and Medicine, Division of Gastroenterology (S.F.G., J.F.R.) The lbert Einstein College of Medicine and Montefiore Medical Center, ronx, New York; and The Lillian and Henry Stratton Hans Popper Department of Pathology, The Mount Sinai Medical Center, New York, New York. Revised manuscript accepted for publication February 9, ddress correspondence and reprint requests to Rosalyn Kutcher, MD, Department of Radiology, The lbert Einstein College of Medicine and Montefiore Medical Center, 111 East 210th Street, ronx, New York assessments of the severity of inflammatory liver injury (grade) and the degree of hepatic scarring (stage) are used to guide clinical management. 2 Gray scale ultrasonography has been reported to detect histologic features of chronic liver disease We compared retrospectively the gray scale liver images and histologic results in hepatitis C patients evaluated with sonographically guided liver biopsy to see if any correlation existed between sonographic and biopsy findings. If a positive correlation did exist, ultrasonography could be an important costeffective means of monitoring the disease in these patients. MTERILS ND METHODS Over a four year period ( ), 77 patients with chronic HCV infection and a positive anti-hcv antibody test (ELIS-2, Ortho-Diagnostics, Raritan, NJ) underwent percutaneous ultrasonographically 1998 by the merican Institute of Ultrasound in Medicine J Ultrasound Med 17: , /98/$3.50
2 322 CHRONIC HEPTITIS C VIRUS INFECTION J Ultrasound Med 17: , 1998 guided liver biopsy at our institution. Sixty-four of these patients formed our study population. Ultrasonograms, liver biopsy results, and clinical information were available for this group. ll images of the liver were acquired with cuson XP 10 and 128 units (cuson, Mountain View, C) using V4, V328, V3.5, or C366 transducers. Two or three core liver biopsies were obtained from the anterior segment of the right lobe in each patient using an 18 gauge needle (ard iopty or Magnum assembly, C.R. ard, Covington, G). Patient age, sex, serum LT level, sonographic size and texture of the liver, and liver histologic findings were reviewed. Size was determined by standard measurement of cranial to caudal length in the right midaxillary line. Sonographic images were classified simultaneously by two blinded readers (R.K., G.S.) as having normal, fatty, fibrofatty, fibrotic, or inflammatory patterns. liver was considered fatty if it demonstrated increased echogenicity, loss of portal venule walls, closely packed echoes, and decreased through-transmission. liver was considered fibrotic if it demonstrated a coarsened echotexture with a pinhead pattern but with preservation of the diaphragm. fibrofatty liver had both fibrotic and fatty features. liver was considered inflammatory if echogenic portal triads were observed in a hypoechoic liver or preservation of portal triads was noted in a background of fatty infiltration. 5,8 If any features of cirrhosis were present, including an irregular contour or nodularity, the liver disease was graded as severe (3) fibrosis. Grading was otherwise done subjectively for degree of severity of the various ultrasonographic patterns. fter the images of the liver were categorized appropriately on the basis of the sonographic pattern, the images within the given category were then graded subjectively on a spectrum as mild (1), moderate (2), or severe (3). iopsy specimens were examined blindly for the presence or absence of steatosis, inflammation, and fibrosis and were graded using the method of Desmet and coworkers. 11 Statistical comparison of sonographic patterns with corresponding histologic findings was performed using a Spearman rank correlation coefficient. Results from a subset of 35 patients with endstage renal disease or a history of end-stage renal disease and a functioning renal allograft were analyzed separately by a Wilcoxon rank sum test for differences in sonographic and histologic findings. ecause biopsy specimens from 12 of these patients were examined by two pathologists (F.S., S.N.T.) separately, the histologic results from these specimens were analyzed for correlation by an intraclass correlation coefficient. RESULTS Clinical evaluations, sonograms, and liver biopsy specimens from 64 patients (39 male, 25 female) aged 17 to 67 years (mean, 43.9 ± 11.6 SD; median, 44 years) were analyzed (Figs. 1 to 3). Liver size was 12 to 20.2 cm (mean, 15.2 cm ± 2 SD). LT values were one to 68 times the ULN (which equaled 40 units) with a mean of 2.9 times the ULN and a median of one times the ULN (54.8%). Thirty-five patients had end-stage renal disease, four had a history of alcohol abuse, two had biopsy-proved cirrhosis, and one had congestive heart failure. Two patients had ascites; Figure 1, Normal liver. Longitudinal ultrasonogram of the right lobe of the liver. Pathologic findings normal., Ultrasonogram: normal; pathologic findings: mild inflammation, mild fibrosis.
3 J Ultrasound Med 17: , 1998 KUTCHER ET L 323 none had hepatoma. No significant clinical history was present in the remaining 22 patients. Correlation was found between abnormal serum levels and histologic inflammation (r = 0.3, P < 0.01) in study patients. Ultrasonographic and histologic findings are presented in Table 1. Note that no sonographic categories were considered inflammatory. No correlation was found between the fatty or fibrofatty patterns on ultrasonography and the histologic findings of steatosis, fibrosis, or inflammation. However, a correlation was found between the fibrotic pattern on ultrasonography and the presence of fibrosis and inflammation at histologic examination (r = 0.27, P = 0.03). In addition, no correlation was noted between grade of fibrosis on ultrasonography and grade of fibrosis on histologic examination. n inverse correlation was observed between increasing liver size and fibrotic pattern on ultrasonography (r = 0.33, P < 0.01). This is expected since the liver shrinks as it becomes increasingly fibrotic or cirrhotic. similar correlation could not be made between liver size and the presence of fibrosis at histologic examination. The reason for this lack of correlation remains unclear, but it may be due to sampling error. In the subset of 35 patients with endstage renal disease, no additional correlation between sonographic findings and histologic findings was present. In the group of 12 patients in whom the biopsy specimens were examined by two pathologists separately, poor interobserver correlation was noted in grading of inflammation and fibrosis (Table 2). DISCUSSION The degree and type of liver injury in patients with acute or chronic liver disease has been difficult to evaluate using ultrasonography, although gray scale criteria for the diagnosis of hepatic inflammation, scarring, and fatty infiltration have been established. We used these criteria in our analysis of sonograms in patients with chronic HCV infection, 3 10 as described in the Materials and Methods section. The difference between fatty, fibrofatty, and fibrotic patterns often was difficult to perceive sonographically. Similarly, the severity of the patterns occurred over a continuous spectrum and was difficult to grade. The ultrasonongraphic pattern of inflammation is the most difficult to perceive, and none of the gray scale images in our series demonstrated either a hypoechoic liver or preserved portal triads. 4,9 lthough these variable gray scale patterns have been described to be typical of fat, fibrosis, and inflammation, this study suggests that these diagnoses are not entirely accurate in patients with chronic HCV infection. When a gray scale sonographic diagnosis of a fibrofatty or fatty liver was made, for example, fat or fibrosis was not necessarily present histologically, and often associated inflammatory changes were present that were not detected at all by ultrasonography. No patient had an inflammatory component on ultrasonography, although 56 patients had this clinically important finding on biopsy. Equally disturbing was the correlation between fibrosis on sonography and the presence of histologic inflammation. Fibrosis is usually a permanent change, whereas inflammation implies an active Figure 2, Ultrasonogram: Mild fatty liver, some loss of portal venule walls, but preservation of diaphragm. Pathologic findings: Moderate inflammation, mild fibrosis, no steatosis., Ultrasonogram: Moderate fatty liver, loss of portal venule walls, tightly packed echoes, and some loss of diaphragm. Pathologic findings: Mild inflammation, mild fibrosis, mild steatosis.
4 324 CHRONIC HEPTITIS C VIRUS INFECTION J Ultrasound Med 17: , 1998 Figure 3, Ultrasonogram: Mild fibrotic liver, coarsened texture with areas of pinhead echoes. Pathologic findings: Moderate inflammation, mild fibrosis, mild steatosis., Ultrasonogram: Severe fibrosis (immediately post biopsy), nodular pattern. Pathologic findings (two readers): mild to severe inflammation, no fibrosis, no steatosis. but potentially reversible process that may resolve without leaving any residual structural abnormality. Two limitations of this study are that it was a retrospective study, and prospective liver evaluation during scanning would likely allow for more accurate parenchymal analysis. Over the 4 year period of data accumulation, equipment and transducers improved, with superior imaging of the liver being possible in the more recent cases. Nevertheless, this study demonstrates that, at the present time, gray scale ultrasonography cannot be used as a method of grading or staging chronic HCV infection, and, by inference, other inflammatory liver diseases with the same histologic abnormalities. ppropriate management of HCV infection requires accurate grading and staging; chronic inflammation with only minimal fibrosis and small amounts of hepatic iron favors a good response to therapy with alpha-interferon 2. iopsy is equally important in the care of patients with other inflammatory liver diseases, many of which cannot be diagnosed accurately without examination of a liver biopsy specimen. correlation was found between elevated serum LT levels and the presence of inflammation on histologic examination. This finding is consistent with the results of other studies, although it is considered to be unreliable by hepatologists, as active disease can be found in patients with low or normal LT levels. It is widely recognized that some variation will occur in interpretation of liver biopsy findings from observer to observer. This was certainly demonstrated in the 12 biopsy specimens that were evaluated by the two pathologists in our study (Table 2). sampling error of up to 10% is accepted for liver biopsies in some diseases. 4 This fact and the findings in our study do raise some concern regarding use of pathologic findings as the gold standard. Since a large portion of our study population had end-stage renal disease, we examined this group as a subset to determine if they had any unique characteristics. Previous studies have shown that HCV infection is not made worse by hemodialyisis or renal transplantation and associated immunosuppression. 10 Findings in the subset of patients with end-stage renal disease evaluated in our study were not different from those in the rest of the study population. Slightly more fat was detected by ultrasonography and biopsy in these patients, a finding that might be related to chronic immunosuppressive therapy with prednisone. Table 1: Comparison of Sonographic Pattern with Histologic Pattern Histologic Pattern (n) Ultrasound (mild moderate severe) Pattern (n) Normal Steatosis Inflammation Fibrosis Normal (14) (5 0 0) (8 2 2) (4 3 0) Fatty (6) (2 2 0) (1 4 0) (3 1 0) Fibrofatty (16) (6 2 2) (7 6 1) (8 3 2) Fibrotic (28) (10 3 0) (9 10 6) (7 7 7)
5 J Ultrasound Med 17: , 1998 KUTCHER ET L 325 Table 2: Interobserver Variation of Histologic Interpretation in 12 Patients fter Double Reading ICC* Path (I) = 0.07 ICC Path (F) = 0.21 ICC Path (S) = 0.78 P < *Intraclass correlation coefficient. I, Inflammation; F, fibrosis; S, fat. In conclusion, although microscopic features of liver disease in patients with chronic HCV infection were detected by ultrasonography, no consistent correlation between sonographic and histologic findings was found, suggesting that ultrasonographic imaging is unreliable for grading and staging the degree of liver damage in chronic HCV infection. REFERENCES Very poor Not correlative Very high 3. Lindnor KD, ru C, Jorgensen R, et al: The role of ultrasonography and automatic needle biopsy in outpatient percutaneous liver biopsy. Hepatology 23:1079, Joseph E: Diffuse liver disease. Clin Diagn Ultrasound 29:1, Taylor KJW, Riely C, Hammers L, et al: Quantitative US attenuation in normal liver and in patients with diffuse liver disease: Importance of fat. Radiology 160:65, Kester NL, LaFortune M, ubin, et al: Focal sparing of liver parenchyma. J Ultrasound Med 15:89, Needleman L, Kurtz, Rifkin MD, et al: Sonography of diffuse benign liver disease. JR 146:1011, Taylor KJW, Gorelick FS, Rosenfield T, et al: Ultrasonography of alcoholic liver disease with histological correlation. Radiology 141:157, Zwiebel WJ: Sonographic diagnosis of diffuse liver disease. Semin Ultrasound CT MRI 16:8, Rosen HR, Friedman LS, Martin P: Hepatitis C and the renal transplant patient. Semin Dialysis 9:39, Desmet VJ, Gerber M, Hoofnagle JH, et al: Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 19:1513, McQuillan GM, lter MJ, Everhart JE: Viral hepatitis. In Everhart JE (Ed): Digestive Diseases in the United States: Epidemiology and Impact. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes, and Digestive and Kidney Diseases. Washington, DC, US Government Printing Office, 1994; NIH publication no p National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes, and Digestive and Kidney Diseases. Washington, DC, US Government Printing Office, 1997 (in press)
Review: How to work up your patient with Hepatitis C
Review: How to work up your patient with Hepatitis C You screened your patient, and now the HCV antibody test is positive. What do you do next? The antibody test only means they have been exposed to HCV.
More informationThe State of the Liver in the Adult Patient after Fontan Palliation
The State of the Liver in the Adult Patient after Fontan Palliation Fred Wu, M.D. Boston Adult Congenital Heart Service Boston Children s Hospital/Brigham & Women s Hospital 7 th National Adult Congenital
More informationCirrhosis and HCV. Jonathan Israel M.D.
Cirrhosis and HCV Jonathan Israel M.D. Outline Relationship of fibrosis and cirrhosisprevalence and epidemiology. Sequelae of cirrhosis Diagnosis of cirrhosis Effect of cirrhosis on efficacy of treatment
More informationGeir Folvik, MD Division of Gastroenterology Department of Medicine, Haukeland University Hospital Bergen, Norway 30.11.2015
Benign liver diseases Geir Folvik, MD Division of Gastroenterology Department of Medicine, Haukeland University Hospital Bergen, Norway 30.11.2015 1 Agenda Benign focal liver lesions Fatty liver disease
More informationSurveillance for Hepatocellular Carcinoma
Surveillance for Hepatocellular Carcinoma Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco Recorded on April
More informationTransmission of HCV in the United States (CDC estimate)
Transmission of HCV in the United States (CDC estimate) Past and Future US Incidence and Prevalence of HCV Infection Decline among IDUs Overall incidence Overall prevalence Infected 20+ years Armstrong
More informationBACKGROUND MEDIA INFORMATION Fast facts about liver disease
BACKGROUND MEDIA INFORMATION Fast facts about liver disease Liver, or hepatic, disease comprises a wide range of complex conditions that affect the liver. Liver diseases are extremely costly in terms of
More informationApproach to Abnormal Liver Tests
Approach to Abnormal Liver Tests Naga P. Chalasani, MD, FACG Professor of Medicine and Cellular & Integrative Physiology Director, Division of Gastroenterology and Hepatology Indiana University School
More informationNP/PA Clinical Hepatology Fellowship Summary of Year-Long Curriculum
OVERVIEW OF THE FELLOWSHIP The goal of the AASLD NP/PA Fellowship is to provide a 1-year postgraduate hepatology training program for nurse practitioners and physician assistants in a clinical outpatient
More informationNoninvasive Means of Diagnosing Liver Fibrosis in Hepatitis C*
530 BJID 2007; 11 (December) Noninvasive Means of Diagnosing Liver Fibrosis in Hepatitis C* Eduardo Sellan Lopes Gonçales, Adriana Flávia Feltrim Angerami and Fernando Lopes Gonçales Junior Study Group
More informationPatterns of abnormal LFTs and their differential diagnosis
Patterns of abnormal LFTs and their differential diagnosis Professor Matthew Cramp South West Liver Unit and Peninsula Schools of Medicine and Dentistry, Plymouth Summary liver function / liver function
More informationNon-alcoholic fatty liver disease: Prognosis and Treatment
Non-alcoholic fatty liver disease: Prognosis and Treatment Zachary Henry, M.D. Assistant Professor UVA Gastroenterology & Hepatology October 28, 2015 Overview Case Presentation Prognosis Effects of fibrosis
More informationEVALUATION OF LIVER FIBROSIS BY FIBROSCAN
EVALUATION OF LIVER FIBROSIS BY FIBROSCAN M. Beaugrand Service d Hépatologied Hopital J. Verdier BONDY 93143 et Université Paris XIII DRESDEN 13.10.2007 ASSESSMENT OF FIBROSIS : WHY? Management of individual
More informationUpdate on Hepatitis C. Sally Williams MD
Update on Hepatitis C Sally Williams MD Hep C is Everywhere! Hepatitis C Magnitude of the Infection Probably 8 to 10 million people in the U.S. are infected with Hep C 30,000 new cases are diagnosed annually;
More informationHepatitis C Treatment Expansion Initiative Multi-Site Conference Call. March 16, 2011
Hepatitis C Treatment Expansion Initiative Multi-Site Conference Call March 16, 2011 Case Presentations Kansas City Free Health Clinic Carilion Clinic Didactic Session Challenges in Determining HCV Treatment
More informationNASH: It is not JUST a Fatty Liver. Karen F. Murray, M.D. Director of Hepatobiliary Program Children s Hospital and Regional Medical Center
NASH: It is not JUST a Fatty Liver Karen F. Murray, M.D. Director of Hepatobiliary Program Children s Hospital and Regional Medical Center Stages of Fatty Liver Disorders Fatty Liver 16-35% of Western
More informationLiver Transplantation for Hepatocellular Carcinoma. John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco
Liver Transplantation for Hepatocellular Carcinoma John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco Hepatocellular Carcinoma HCC is the 5th most common
More informationEvaluation and Follow-up of Fetal Hydronephrosis
Evaluation and Follow-up of Fetal Hydronephrosis Deborah M. Feldman, MD, Marvalyn DeCambre, MD, Erin Kong, Adam Borgida, MD, Mujgan Jamil, MBBS, Patrick McKenna, MD, James F. X. Egan, MD Objective. To
More informationRecanalized Umbilical Vein in the Presence of Cirrhosis-Induced Portal Hypertension
Recanalized Umbilical Vein in the Presence of Cirrhosis-Induced Portal Hypertension Audrey Galey RDMS, RVT, Mary Grace Renfro RDSM, RVT, Lindsey Simon, RVT March 22, 2013 2 Abstract A recanalized umbilical
More informationSonographic Demonstration of Couinaud s Liver Segments
PICTORIL ESSY Sonographic Demonstration of Couinaud s Liver Segments Dean Smith, MD, FRCPC, Donal Downey, M, Ch, FRCPC, lison Spouge, MD, FRCPC, Sue Soney, RT, RDMS, RCMS The segmental localization of
More informationHIV and Hepatitis Co-infection. Martin Fisher Brighton and Sussex University Hospitals, UK
HIV and Hepatitis Co-infection Martin Fisher Brighton and Sussex University Hospitals, UK Useful References British HIV Association 2010 http://www.bhiva.org/documents/guidelines/hepbc/2010/ hiv_781.pdf
More informationManagement of hepatitis C: pre- and post-liver transplantation. Piyawat Komolmit Bangkok
Management of hepatitis C: pre- and post-liver transplantation Piyawat Komolmit Bangkok Liver transplantation and CHC Cirrhosis secondary to HCV is the leading cause of liver transplantation in the US
More informationAmylase and Lipase Tests
Amylase and Lipase Tests Also known as: Amy Formal name: Amylase Related tests: Lipase The Test The blood amylase test is ordered, often along with a lipase test, to help diagnose and monitor acute or
More informationAlanine aminotransferase (serum, plasma)
Alanine aminotransferase (serum, plasma) 1 Name and description of analyte 1.1 Name of analyte Alanine aminotransferase (ALT) 1.2 Alternative names Systematic name L alanine:2 oxoglutarate aminotransferase
More informationMRI of Bone Marrow Radiologic-Pathologic Correlation
MRI of Bone Marrow Radiologic-Pathologic Correlation Marilyn J. Siegel, M.D. Mallinckrodt Institute of Radiology Washington University School of Medicine St. Louis, MO and Visiting Scientist, AFIP, Washington,
More informationThe Epidemiology of Hepatitis A, B, and C
The Epidemiology of Hepatitis A, B, and C Jamie Berkes M.D. University of Illinois at Chicago jberkes@uic.edu Epidemiology: Definitions The study of the incidence and prevalence of diseases in large populations
More informationBURDEN OF LIVER DISEASE IN BRAZIL
BURDEN OF LIVER DISEASE IN BRAZIL Burden of Liver Disease in Europe Blachier et al. J Hepatol 58:593, 2013 Review of 260 epidemiologic studies of the 5 previous years Cirrhosis is responsible for 170.000
More informationLIVER FUNCTION TESTS AND STATINS
LIVER FUNCTION TESTS AND STATINS Philippe J. Zamor and Mark W. Russo Current Opinion in Cardiology 2011,26:338 341 SUMMARY Purpose of review: To discuss recent data on statins in patients with elevated
More informationDifferential Diagnosis of NAFLD- A Short Summary:
Differential Diagnosis of NAFLD- A Short Summary: Almost a fifth of our general pediatric population is now classified as overweight in the United States. When such children present with elevated liver
More informationLIVER CANCER AND TUMOURS
LIVER CANCER AND TUMOURS LIVER CANCER AND TUMOURS Healthy Liver Cirrhotic Liver Tumour What causes liver cancer? Many factors may play a role in the development of cancer. Because the liver filters blood
More informationGT-020 Phase 1 Clinical Trial: Results of Second Cohort
GT-020 Phase 1 Clinical Trial: Results of Second Cohort July 29, 2014 NASDAQ: GALT www.galectintherapeutics.com 2014 Galectin Therapeutics inc. Forward-Looking Statement This presentation contains, in
More informationPREVENTION OF HCC BY HEPATITIS C TREATMENT. Morris Sherman University of Toronto
PREVENTION OF HCC BY HEPATITIS C TREATMENT Morris Sherman University of Toronto Pathogenesis of HCC in chronic hepatitis C Injury cirrhosis HCC Injury cirrhosis HCC Time The Ideal Study Prospective randomized
More informationMANAGEMENT OF LIVER CIRRHOSIS
MANAGEMENT OF LIVER CIRRHOSIS Information Leaflet Your Health. Our Priority. Page 2 of 6 What is cirrhosis? Cirrhosis is a result of long-term, continuous damage to the liver and may be due to many different
More informationPrognosis of Very Large First-Trimester Hematomas
Case Series Prognosis of Very Large First-Trimester Hematomas Juliana Leite, MD, Pamela Ross, RDMS, RDCS, A. Cristina Rossi, MD, Philippe Jeanty, MD, PhD Objective. The aim of this study was to evaluate
More informationEpidemiology of Hepatitis C Infection. Pablo Barreiro Service of Infectious Diseases Hospital Carlos III, Madrid
Epidemiology of Hepatitis C Infection Pablo Barreiro Service of Infectious Diseases Hospital Carlos III, Madrid Worldwide Prevalence of Hepatitis C 10% No data available WHO.
More informationWhat to Expect from Intestinal Ultrasonography
261) What to Expect from Intestinal Ultrasonography Červenková J., Steyerová P. Charles University in Prague, First Faculty of Medicine and General Teaching Hospital, Department of Radiology, Prague, Czech
More informationHepatitis C Treatment Criteria Commercial & Minnesota Health Care Programs
Last update: February 23, 2015 Hepatitis C Treatment Criteria Commercial & Minnesota Health Care Programs Please see healthpartners.com for Medicare coverage criteria. Table of Contents 1. Harvoni 2. Sovaldi
More informationLYMPHOMA IN DOGS. Diagnosis/Initial evaluation. Treatment and Prognosis
LYMPHOMA IN DOGS Lymphoma is a relatively common cancer in dogs. It is a cancer of lymphocytes (a type of white blood cell) and lymphoid tissues. Lymphoid tissue is normally present in many places in the
More informationHEPATITIS WEB STUDY Acute Hepatitis C Virus Infection: Epidemiology, Clinical Features, and Diagnosis
HEPATITIS WEB STUDY Acute C Virus Infection: Epidemiology, Clinical Features, and Diagnosis H. Nina Kim, MD Assistant Professor of Medicine Division of Infectious Diseases University of Washington School
More informationAbnormal Liver Function. Dr William Alazawi MA(Cantab) PhD MRCP Senior Lecturer and Consultant in Hepatology Queen Mary, University of London
Abnormal Liver Function Dr William Alazawi MA(Cantab) PhD MRCP Senior Lecturer and Consultant in Hepatology Queen Mary, University of London Does Liver Disease Matter? Mortality in England & Wales Liver-related
More information2.1 AST can be measured in heparin plasma or serum. 3 Summary of clinical applications and limitations of measurements
Aspartate aminotransferase (serum, plasma) 1 Name and description of analyte 1.1 Name of analyte Aspartate aminotransferase (AST) 1.2 Alternative names Systematic name L aspartate:2 oxoglutarate aminotransferase
More informationSoft Tissue Diffuse Neurofibromas
ase Series Soft Tissue Diffuse Neurofibromas Sonographic Findings Wen hen, MD, Jian-Wen Jia, MD, Jin-Rui Wang, MD Objective. The purpose of this study was to describe the sonographic findings of soft tissue
More informationUCLA Asian Liver Program
CLA Program Update Program Faculty Myron J. Tong, PhD, MD Professor of Medicine Hepatology Director, Asian Liver Program Surgery Ronald W. Busuttil, MD, PhD Executive Chair Department of Surgery Director,
More informationLIVER. Update on Staging of Fibrosis and Cirrhosis. Staging and Liver Fibrosis. Stage is more than liver fibrosis
Linda Ferrell, MD Distinguished Professor Vice Chair Director of Surgical Pathology Dept of Pathology LIVER Update on Staging of Fibrosis and Cirrhosis Staging and Liver Fibrosis Two important concepts
More informationNon-invasive evaluation of liver fibrosis: current clinical use and next perspectives (chronic hepatitis C)
Non-invasive evaluation of liver fibrosis: current clinical use and next perspectives (chronic hepatitis C) Paul Calès Liver and Gastroenterology department, University hospital & HIFIH laboratory, Angers
More informationAfter the Cure: Long-Term Management of HCV Liver Disease Norah A. Terrault, MD, MPH
After the Cure: Long-Term Management of HCV Liver Disease Norah A. Terrault, MD, MPH Professor of Medicine Department of Gastroenterology Director, Viral Hepatitis Center University of California San Francisco
More informationProf. of Tropical Medicine Faculty of Medicine Alexandria University
prof. Dr. Ali El-Kady (MD) Prof. of Tropical Medicine Faculty of Medicine Alexandria University DRUGS THAT MAY CAUSE LIVER DYSFUNCTION DAMAGE The liver is the principal organ that is capable of converting
More informationHEPATITIS C. The Facts. Get Tested. Get Cured! Health
HEPATITIS C The Facts Get Tested. Get Cured! Health EVEN IF YOU FEEL HEALTHY, HEPATITIS C MAY BE DAMAGING YOUR LIVER. Your liver keeps you healthy in many ways, such as by removing toxins from your blood
More informationLiver Function Tests - The Downside
KAPIL CHOPRA, MD 1 So I'm going to kickoff this course with the topic of abnormal liver function tests. To be very honest this is a huge topic. I think to do justice I'm going to try and touch on some
More informationLamivudine for Patients with hronic Hepatitis B and Advanced Liver Disease. From : New England Journal of Medicine
Lamivudine for Patients with hronic Hepatitis B and Advanced Liver Disease From : New England Journal of Medicine Volume 351:1521-1531, Number 15, Oct 7, 2004 馬 偕 紀 念 醫 院 一 般 內 科, 肝 膽 腸 胃 科 新 竹 分 院 陳 重
More informationWhat to Do with the Patient With Abnormal Liver Enzymes? Nizar N. Zein, M.D. The Cleveland Clinic
What to Do with the Patient With Abnormal Liver Enzymes? Nizar N. Zein, M.D. The Cleveland Clinic Introduction Elevated liver enzymes is often not a clinical problem by itself. However it is a warning
More informationNON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN MEN WITH TYPE 2 DIABETES
NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN MEN WITH TYPE 2 DIABETES D. Bakalov 1, M. Boyanov 1, G. Sheinkova 1, L. Vezenkova 1, G. Prodanova 2, V. Christov 1 1 Endocrinology Clinic 2 Sonography unit
More informationSonographic Diagnosis of Ureteral Tumors
Sonographic Diagnosis of Ureteral Tumors Irith Hadas-Halpern, MD, micur Farkas, MD, Michael Patlas, MD, Ibrahim Zaghal, MD, Shoshana Sabag-Gottschalk, MD, Drora Fisher, MD We present our experience with
More informationHepatitis C. David Mutimer Queen Elizabeth Hospital Liver Unit Birmingham. Substance Misuse Treatment in the West Midlands. How can we reduce harm?
Hepatitis C David Mutimer Queen Elizabeth Hospital Liver Unit Birmingham Substance Misuse Treatment in the West Midlands. How can we reduce harm? Birmingham October 19 th 2007 infection HCV Natural History
More informationOvarian Torsion: Sonographic Evaluation
J Clin Ultrasound 17:327-332, June 1989 Ovarian Torsion: Sonographic Evaluation Mark A. Helvie, MD,* and Terry M. Silver, MDI Abstract: The sonographic and clinical findings of 13 patients with surgically
More informationLCD for Viral Hepatitis Serology Tests
LCD for Viral Hepatitis Serology Tests Applicable CPT Code(s): 86692 Antibody; Hepatitis, Delta Agent 86704 Hepatitis B Core Antibody (HBcAb); Total 86705 Hepatitis B Core Antibody (HBcAb); IgM Antibody
More information2015 Outpatient Chronic Hepatitis B Management
2015 Outpatient Chronic Hepatitis B Management Hepatitis B Hepatitis B Info 70% of acute infections are subclinical More severe symptoms when in addition to other liver disease Fulminant Hepatitis
More informationHepatitis C Glossary of Terms
Acute Hepatitis C A short-term illness that usually occurs within the first six months after someone is exposed to the hepatitis C virus (HCV). 1 Antibodies Proteins produced as part of the body s immune
More information190.33 - Hepatitis Panel/Acute Hepatitis Panel
190.33 - Hepatitis Panel/Acute Hepatitis Panel This panel consists of the following tests: Hepatitis A antibody (HAAb), IgM antibody; Hepatitis B core antibody (HBcAb), IgM antibody; Hepatitis B surface
More informationElevated heart rate at twelve months after heart transplantation is an independent predictor of long term mortality
Elevated heart rate at twelve months after heart transplantation is an independent predictor of long term mortality C. Tomas, MA Castel, E Roig, I. Vallejos, C. Plata, F. Pérez-Villa Cardiology Department,
More informationComparative Levels of ALT, AST, ALP and GGT in Liver associated Diseases
Available online at wwwpelagiaresearchlibrarycom European Journal of Experimental Biology, 2013, 3(2):280-284 ISSN: 2248 9215 CODEN (USA): EJEBAU Comparative Levels of ALT, AST, ALP and GGT in Liver associated
More informationCommonly Asked Questions About Chronic Hepatitis C
Commonly Asked Questions About Chronic Hepatitis C From the American College of Gastroenterology 1. How common is the hepatitis C virus? The hepatitis C virus is the most common cause of chronic viral
More informationViral Hepatitis A, B, and C
Viral Hepatitis A, B, and C What is Hepatitis? Hepatitis means inflammation of the liver Elizabeth A. Bancroft, MD, SM Acute Communicable Disease Control County of Los Angeles Department of Public Health
More informationNew IDSA/AASLD Guidelines for Hepatitis C
NORTHWEST AIDS EDUCATION AND TRAINING CENTER New IDSA/AASLD Guidelines for Hepatitis C John Scott, MD, MSc Associate Professor, UW SoM Asst Director, Liver Clinic, Harborview Medical Center Presentation
More informationUltrasonography of the Adrenal Glands CVM 6105 Kari L. Anderson, DVM, Diplomate ACVR Associate Clinical Professor of Veterinary Radiology
1: US of adrenal glands, KLA Ultrasonography of the Adrenal Glands CVM 6105 Kari L. Anderson, DVM, Diplomate ACVR Associate Clinical Professor of Veterinary Radiology Ultrasound has quickly become an important
More informationELEMENTS FOR A PUBLIC SUMMARY. Overview of disease epidemiology. Summary of treatment benefits
VI: 2 ELEMENTS FOR A PUBLIC SUMMARY Bicalutamide (CASODEX 1 ) is a hormonal therapy anticancer agent, used for the treatment of prostate cancer. Hormones are chemical messengers that help to control the
More informationService Definition with all Clinical Terms Service: Laprascopic Cholecystectomy Clinic (No Gallstones in bile duct)
Service Definition with all Clinical Terms Service: Laprascopic Cholecystectomy Clinic (No Gallstones in bile duct) Section 1 Service Details Service ID: 7540540 Service Comments: Referrer Alert: Service
More informationAlbumin. Prothrombin time. Total protein
Hepatitis C Fact Sheet February 2016 www.hepatitis.va.gov Laboratory Tests and Hepatitis If you have hepatitis C, your doctor will use laboratory tests to about learn more about your individual hepatitis
More informationOpportunities for advancing biomarkers for patient stratification and early diagnosis in liver disease
Opportunities for advancing biomarkers for patient stratification and early diagnosis in liver disease 80 Liver Disease and Obesity Liver disease biomarkers: Percent of adult population (United States)
More informationHepatocellular Carcinoma: A Guide to Screening and Diagnosis
February 2012 Hepatocellular Carcinoma: A Guide to Screening and Diagnosis Reid Merryman, Harvard Medical School Year III Agenda Hepatocellular carcinoma (HCC) introduction Index patient: clinical presentation
More informationResults Demographic profile of these children is shown in Table I.
Prevalence of Antibody to Hepatitis C Virus in Pakistani Thalassaemics by Particle Agglutination Test Utilizing C 200 and C 22-3 Viral Antigen Coated Particles Pages with reference to book, From 269 To
More information"Lucian Blaga"University Sibiu Faculty of Medicine Victor Papilian. EVALUATION OF LIVER FIBROSIS IN CHRONIC VIRAL HEPATITIS C. PhD thesis abstract
"Lucian Blaga"University Sibiu Faculty of Medicine Victor Papilian EVALUATION OF LIVER FIBROSIS IN CHRONIC VIRAL HEPATITIS C. PhD thesis abstract Scientific coordinator Prof. Dr. Mircea DEAC PhD student
More informationSubproject 4: Specification and Documentation of Metabolic and Neoplastic Diseases
Subproject 4: Specification and Documentation of Metabolic and Neoplastic Diseases M. Trauner, Division of Gastroenterology and Hepatology, Department of Internal Medicine, MUG Co- Investigator: H. Samonigg,
More informationNon-Alcoholic Fatty Liver Disease
Non-Alcoholic Fatty Liver Disease Information for patients and families UHN Read this information to learn: what non-alcoholic fatty liver disease is what causes it how it s treated how to prevent it where
More informationEarly Prostate Cancer: Questions and Answers. Key Points
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Early Prostate Cancer:
More informationLiver Diseases. An Essential Guide for Nurses and Health Care Professionals
Brochure More information from http://www.researchandmarkets.com/reports/1047385/ Liver Diseases. An Essential Guide for Nurses and Health Care Professionals Description: Liver disease is a rapidly growing
More information3/25/2014. April 3, 2014. Dennison MM, et al. Ann Intern Med. 2014;160:293 300.
April 3, 2014 3.6 million persons ever infected; 2.7 million chronic infections 1 Up to 75% unaware of status Transmitted through percutaneous exposure to infected blood Injection drug use (IDU) is the
More informationIncidence of Incidental Thyroid Nodules on Computed Tomography (CT) Scan of the Chest Performed for Reasons Other than Thyroid Disease
International Journal of Clinical Medicine, 2011, 2, 264-268 doi:10.4236/ijcm.2011.23042 Published Online July 2011 (http://www.scirp.org/journal/ijcm) Incidence of Incidental Thyroid Nodules on Computed
More informationIntroduction Breast cancer is cancer that starts in the cells of the breast. Breast cancer happens mainly in women. But men can get it too.
Male Breast Cancer Introduction Breast cancer is cancer that starts in the cells of the breast. Breast cancer happens mainly in women. But men can get it too. Many people do not know that men can get breast
More informationOptimal imaging surveillance schedules after liver directed therapy for hepatocellular carcinoma
Optimal imaging surveillance schedules after liver directed therapy for hepatocellular carcinoma F. Edward Boas, MD, PhD; Bao Do, MD; John D. Louie, MD; Nishita Kothary, MD; Gloria L. Hwang, MD; William
More informationPreparation iagnostic Medical Sonographer Overview"
Diagnostic Medical Sonographer Overview The Field - Preparation - Specialty Areas - Day in the Life - Earnings - Employment - Career Path Forecast - Professional Organizations The Field Diagnostic imaging
More informationLiving with HEP C. Facts about Hepatitis C
Living with HEP C Facts about Hepatitis C IMPORTANT The information in this booklet is intended for people who are newly diagnosed with Hepatitis C (called Hep C for short). It can help you learn more
More informationHCV: Diagnostic Testing and Staging. HCV: Diagnostic Tests
HCV: Diagnostic Testing and Staging HCV: Diagnostic Tests Necessary HCV Antibody HCV-RNA Genotype Not Necessary ALT IL28 B 1 ALT as a Sole Trigger for Screening Misses Some Infected Patients Patients*
More informationEstimation of Fetal Weight: Mean Value from Multiple Formulas
Estimation of Fetal Weight: Mean Value from Multiple Formulas Michael G. Pinette, MD, Yuqun Pan, MD, Sheila G. Pinette, RPA-C, Jacquelyn Blackstone, DO, John Garrett, Angelina Cartin Mean fetal weight
More informationSHAHID AZIZ DO, FACOI.
SHAHID AZIZ DO, FACOI. ASSOCIATE CLINICAL PROFESSOR OF GI AND LIVER DISEASE. UT SOUTHWESTERN HEALTH SCIENCE CENTER, DALLAS ADJUNCT CLINICAL ASSISTANT PROFESSOR DEPT OF MEDICINE UNT HEALTH SCIENCE CENTER
More informationThe most serious symptoms of this stage are:
The Natural Progression of Hepatitis C The natural history of hepatitis C looks at the likely outcomes for people infected with the virus if there is no medical intervention. However, the process of trying
More informationFibrosis and other histological features in chronic hepatitis C virus infection: a statistical model
J Clin Pathol 1996;49:465-469 Fibrosis and other histological features in chronic hepatitis C virus infection: a statistical model 465 V S Wong, D G D Wight, C R Palmer, G J M Alexander Department of Medicine,
More informationCase Study in the Management of Patients with Hepatocellular Carcinoma
Management of Patients with Viral Hepatitis, Paris, 2004 Case Study in the Management of Patients with Hepatocellular Carcinoma Eugene R. Schiff This 50-year-old married man with three children has a history
More informationSonography of Partial-Thickness Quadriceps Tendon Tears With Surgical Correlation
Article Sonography of Partial-Thickness Quadriceps Tendon Tears With Surgical Correlation Samuel La, MD, David P. Fessell, MD, John E. Femino, MD, Jon A. Jacobson, MD, David Jamadar, MB, BS, Curtis Hayes,
More informationEMERGING CLINICAL ISSUE: HEPATITIS C INFECTION IN HIV-INFECTED MEN WHO HAVE SEX WITH MEN
EMERGING CLINICAL ISSUE: HEPATITIS C INFECTION IN HIV-INFECTED MEN WHO HAVE SEX WITH MEN JUNE 2014 INTRODUCTION Approximately 3.2 million individuals in the United States are infected with chronic hepatitis
More informationHEPATITIS COINFECTIONS
HEPATITIS COINFECTIONS Kenneth E. Sherman, MD, PhD Gould Professor of Medicine Director, Division of Digestive Diseases University of Cincinnati College of Medicine Disclosures (Activity w/i 12 months)
More informationKIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA
KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA O.E. Stakhvoskyi, E.O. Stakhovsky, Y.V. Vitruk, O.A. Voylenko, P.S. Vukalovich, V.A. Kotov, O.M. Gavriluk National Canсer Institute,
More informationViral Hepatitis. 2009 APHL survey report
Issues in Brief: viral hepatitis testing Association of Public Health Laboratories May Viral Hepatitis Testing 9 APHL survey report In order to characterize the role that the nation s public health laboratories
More informationNUTRITION IN LIVER DISEASES
NUTRITION IN LIVER DISEASES 1. HEPATITIS: Definition: - Viral inflammation of liver cells. Types: a. HAV& HEV, transmitted by fecal-oral route. b. HBV & HCV, transmitted by blood and body fluids. c. HDV
More informationAcute on Chronic Liver Failure: Current Concepts. Disclosures
Acute on Chronic Liver Failure: Current Concepts Vandana Khungar, MD MSc Assistant Professor of Medicine University of Pennsylvania, Perelman School of Medicine September 20, 2015 None to declare Disclosures
More informationPREPARED BY THE CENTER FOR HEALTH LAW AND POLICY INNOVATION OF HARVARD LAW SCHOOL
Pennsylvania PREPARED BY THE CENTER FOR HEALTH LAW AND POLICY INNOVATION OF HARVARD LAW SCHOOL Pennsylvania Hepatitis C Virus (HCV) in Pennsylvania Prevalence + + Although state-wide data were unavailable,
More informationThe degree of liver inflammation or damage (grade) Presence and extent of fatty liver or other metabolic liver diseases
ilearning about your health Liver Biopsy www.cpmc.org/learning What is a Liver Biopsy? A liver biopsy is a procedure where a specially trained doctor (typically a hepatologist, radiologist, or gastroenterologist)
More informationWhat does Hepatitis C mean to me as a CKD Patient?
What does Hepatitis C mean to me as a CKD Patient? Clinical Practice Guidelines for the Prevention, Diagnosis, Evaluation and Treatment of Hepatitis C in CKD Introduction Worldwide, about 170 million people
More informationCANCER OF THE LIVER HEPATOCELLULAR CARCINOMA
CANCER OF THE LIVER HEPATOCELLULAR CARCINOMA WHAT IS CANCER OF THE LIVER? Hepatocellular carcinoma is the most common form and it comes from the main type of liver cell, the hepatocyte. About 3 out 4
More information